Event Description
Respiratory virus season continues to evolve, bringing new recommendations, changing epidemiology, and updated prevention strategies. Join us for an evidence-based review of the latest developments in pediatric RSV, influenza, and COVID-19 for the 2026–2027 respiratory virus season. This webinar will examine current trends in pediatric respiratory infections, identify children at greatest risk for severe disease, and review the latest guidance on vaccination, prevention, and treatment. Participants will leave with practical, up-to-date information to help prepare for the upcoming season and support clinical decision-making in pediatric practice.
About the Speaker
Tracie Newman, MD, MPH, FAAP is a board-certified pediatrician and previously served as Health Officer of the City of Fargo. At NDSU, she is an Associate Professor of Practice in the Department of Public Health and medical director of the Center for Immunization Research and Education (CIRE). She is also an Associate Clinical Professor at the University of North Dakota School of Medicine. Dr. Newman received her medical training at the University of North Dakota and completed a pediatrics residency and obtained a masters degree in public health at the University of Minnesota. She was an elected member to the Executive Committee and served as Policy Chair for the Council on School Health for the American Academy of Pediatrics.
Continuing Education
Instructions for claiming continuing education credit are provided during the webinar.
For questions regarding continuing education, please email cire.cme@ndsu.edu.
Continuing Medical Education (CME)
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Minnesota Medical Association and NDSU. The Minnesota Medical Association (MMA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Minnesota Medical Association designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education (CPE)
This activity is approved for 0.1 CEU of pharmacist and pharmacy technician credit by CEImpact. CEimpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
More information is available via the NDSU CAP Center.
